Walgreens Boots Alliance Inc (WBA) Holdings Lessened by Gamble Jones Investment Counsel

Gamble Jones Investment Counsel cut its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 0.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 19,471 shares of the pharmacy operator’s stock after selling 150 shares during the quarter. Gamble Jones Investment Counsel’s holdings in Walgreens Boots Alliance were worth $1,330,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of WBA. Bank of New York Mellon Corp grew its holdings in shares of Walgreens Boots Alliance by 71,970.7% during the third quarter. Bank of New York Mellon Corp now owns 11,640,855 shares of the pharmacy operator’s stock worth $848,617,000 after buying an additional 11,624,703 shares in the last quarter. Franklin Resources Inc. grew its holdings in shares of Walgreens Boots Alliance by 21.5% during the third quarter. Franklin Resources Inc. now owns 18,789,390 shares of the pharmacy operator’s stock worth $1,369,796,000 after buying an additional 3,318,524 shares in the last quarter. Capital World Investors grew its holdings in shares of Walgreens Boots Alliance by 18.2% during the third quarter. Capital World Investors now owns 18,089,012 shares of the pharmacy operator’s stock worth $1,318,689,000 after buying an additional 2,790,213 shares in the last quarter. LSV Asset Management grew its holdings in shares of Walgreens Boots Alliance by 28.5% during the third quarter. LSV Asset Management now owns 11,183,914 shares of the pharmacy operator’s stock worth $815,307,000 after buying an additional 2,479,681 shares in the last quarter. Finally, Capital International Investors grew its holdings in shares of Walgreens Boots Alliance by 24.4% during the third quarter. Capital International Investors now owns 11,545,175 shares of the pharmacy operator’s stock worth $841,643,000 after buying an additional 2,266,950 shares in the last quarter. Institutional investors and hedge funds own 66.57% of the company’s stock.

WBA has been the subject of a number of analyst reports. Needham & Company LLC upgraded Walgreens Boots Alliance to a “buy” rating and set a $94.00 price target for the company in a research note on Thursday, December 20th. Loop Capital set a $82.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Thursday, December 20th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $92.00 price target for the company in a research note on Friday, November 30th. BidaskClub downgraded Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 18th. Finally, Morgan Stanley raised their price target on Walgreens Boots Alliance from $55.00 to $77.00 and gave the company an “equal weight” rating in a research note on Monday, December 3rd. Four research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $78.83.

WBA opened at $70.12 on Monday. Walgreens Boots Alliance Inc has a 12-month low of $59.07 and a 12-month high of $86.31. The company has a market capitalization of $66.15 billion, a PE ratio of 11.65, a price-to-earnings-growth ratio of 1.10 and a beta of 0.98. The company has a quick ratio of 0.36, a current ratio of 0.80 and a debt-to-equity ratio of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.43 by $0.03. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The company had revenue of $33.79 billion during the quarter, compared to analysts’ expectations of $33.90 billion. During the same period last year, the firm posted $1.28 earnings per share. The business’s revenue was up 9.9% on a year-over-year basis. As a group, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 6.52 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 12th. Stockholders of record on Friday, February 15th will be given a $0.44 dividend. The ex-dividend date is Thursday, February 14th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.51%. Walgreens Boots Alliance’s payout ratio is 29.24%.

In related news, Director Nancy M. Schlichting sold 7,050 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, November 20th. The stock was sold at an average price of $78.81, for a total transaction of $555,610.50. Following the completion of the sale, the director now directly owns 5,709 shares of the company’s stock, valued at approximately $449,926.29. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 15.73% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2019/02/11/walgreens-boots-alliance-inc-wba-holdings-lessened-by-gamble-jones-investment-counsel.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Recommended Story: What is the return on assets formula?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.